Maggot therapy for calciphylaxis wound debridement complicated by bleeding
Allen F. Shih, AM, Alicia J. Little, MD, PhD, Gauri Panse, MD and 4 more
JAAD Case Reports · 2018
doi:10.1016/j.jdcr.2018.01.011 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Calciphylaxis is a rare disease with significant morbidity and mortality. Reported 1-year mortality is up to 80%, with sepsis as the leading cause of death.1 Although most cases occur in end-stage renal disease patients on dialysis, nonuremic cases also occur. Maggot therapy for wound debridement in calciphylaxis has been reported, but the literature is limited.
Abstract licence: CC BY-NC-ND
References10
10 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.